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A Motif within the T Cell Receptor a Chain
Constant Region Connecting Peptide Domain
Controls Antigen Responsiveness
B. Thomas Ba¨ckstro¨m,* Elisabetta Milia,† of different signals. The TCR complex does not function
Annick Peter,* Beltran Jaureguiberry,‡ as a simple on–off switch upon activation. Instead, the
Cosima T. Baldari,† and Ed Palmer* TCR is capable of delivering a variety of different signals,
*Basel Institute for Immunology leading to distinct cytokine profiles and effector func-
CH-4005 Basel tions (Evavold et al., 1993; Racioppi and Germain, 1995;
Switzerland Sette et al., 1994; Jameson and Bevan, 1995). TCR en-
†Department of Evolutionary Biology gagement rapidly induces phosphorylation of the CD3
University of Siena and z chains at tyrosine residues in the conserved im-
Via Mattioli 4 munoreceptor tyrosine-based activation motif (ITAM)
53100 Siena (Reth, 1989; Ashwell and Klausner, 1990; Malissen and
Italy Schmitt-Verhulst, 1993; Chan et al., 1994; Zenner et al.,
‡Veterquimica LTD 1995). Whereas the CD3gde chains each contain one
Research and Development Department ITAM and the z chain contains three ITAMs, the relation-
Camino a Melipilla 5641 ship between the individual CD3/z chain ITAMs and T
Los Cerrillos-Santiago cell function is unknown. However, these ITAMs provide
Chile the structural basis for linking the extracellular recogni-
tion of peptide–MHC antigens by the TCR to the intracel-
lular signaling machinery. The cytoplasmic protein tyro-
Summary sine kinases Lck, Fyn, and ZAP-70 interact directly with
the CD3/z chain ITAMs upon T cell activation. The re-
Mutant ab TCRs weregenerated by replacing domains cruitment of these protein tyrosine kinases to phosphor-
of the a andb chainconstant regions with homologous ylated ITAMs is essential for T cell activation and influ-
domains from TCR d and g chains, respectively. Chi- ences several downstream cellular responses, such as
meric TCRs in which the a chain contains TCR d chain the activation of phospholipase C (PLC), the mobilization
sequences within the connecting peptide domain are of cytoplasmic free calcium ([Ca21]i), and the activationunresponsive to alloantigens and superantigens, and of Ras proteins (Weiss and Littman, 1994; Clevers et al.,
have defective interactions with the CD3/z complex. 1988; Finkel et al., 1991). Activation of PLC-g1 in T cells
Although these antigen-unresponsive TCRs undergo results in the hydrolysis of phosphatidylinositol (4,5)bis-
z chain phosphorylation upon stimulation with super-
phosphate, yielding the second messengers diacylglyc-
antigen, they do not generate a full signal capable of erol and inositol 1,4,5-trisphosphate (IP3). Whereas diac-producing IL-2. Mutant TCRs acquire signaling activity
ylglycerol activates the protein kinase C (PKC), IP3with a combination of superantigen and calcium iono-
triggers release of Ca21 from the endoplasmic reticulum.phore, indicating a defect in calcium-mediated signal-
These independent signals are required for interleu-ing. Finally, a conserved motif, FETDxNLN, present in
kin-2 (IL-2) production, but the principal mediator of IL-2the a chain connecting peptide domain, is disrupted
promoter activation is the transcription factor NF-ATin all signaling-defective TCRs. This conserved a chain
(Serfling et al., 1995). NF-AT is exquisitely dependentconnecting peptide motif might mediate the transfer of
on TCR engagement for activation and neither requiressignals from the ab heterodimer to the CD3/z complex.
nor responds to costimulatory signals (Baldari et al.,
1993).
A second TCR, gd, is related to the ab antigen recep-Introduction
tor, but is expressed on distinct T cell populations (Haas
et al., 1993). The ab and gd TCRs are similar in that theyEngagement of the T cell receptor (TCR) with its specific
show sequence homology in the variable and constantpeptide–major histocompatibility complex (MHC) ligand
regions, interact with the same CD3 and z chains, andis an absolute requirement for the development and
mediate signal transduction upon antigen recognition.activation of immunocompetent T cells (von Boehmer,
However, the gd TCR differs from its ab relative in some1994; Ashwell and Klausner, 1990; Weiss and Littman,
respects. For example, gd TCRs can interact with the1994). The TCR complex consists of an ab heterodimer
CD3 complex in a structurally distinct manner (Krangelnoncovalently associated with the CD3gde and z chains
et al., 1987), respond directly to antigens without MHC(Clevers et al., 1988; Ashwell and Klausner, 1990; Weiss,
presentation (Sciammas et al., 1994; Schild et al., 1994),1991). The TCR variable regions recognize peptides
and utilize distinct receptor signaling components (Qianbound to MHC proteins, and the constant regions inter-
et al., 1993). Two important questions remain regardingact with the CD3/z complex, which is necessary for cor-
the function of these receptors: how do ab (and gd)rect assembly in the endoplasmic reticulum and stable
TCRs occupied with an antigenic ligand transfer signalscell surface expression. Each TCR constant region con-
to the CD3/z complex, and which domains of the TCRsists of immunoglobulin-like, connecting peptide (CP),
constant regions are involved?transmembrane (TM), and cytoplasmic (Cyto) domains
We took advantage of the similarities and differences(Hayday et al., 1985a; Malissen et al., 1984).
between ab and gd TCRs and produced chimeric TCRThe structural complexity of the TCR in comparison
a and b chains containing different lengths of TCR dwith the interleukin and growth factor families of recep-
tors indicates that the TCR might transduce a number and g chain sequences, respectively. We have initially
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Figure 1. Amino Acid Sequence of the TCR Chimeric a-d and b-g Chains
(A) The sequences of the wild-type TCR a chain (awt) and the five chimeric TCR a-d chains (aI–aV) are shown using the single-letter amino
acid code. The boxes indicate the TCR d chain–derived amino acids.
(B) The sequences of the wild-type TCR b chain (bwt) and the three chimeric TCR b-g chains (bI–bIII) are shown using the single-letter amino
acid code. The boxes indicate the TCR g chain–derived amino acids.
Only the CP, TM, and Cyto domains of the TCR constant regions are shown. The VJa, Ca, VDJb, and Cb sequences, not shown in the
figure, are derived from the a and b chain cDNAs obtained from the 3BBM74 T cell hybridoma (DiGiusto and Palmer, 1994). The N-terminal
amino acid in (A) represents the intrachain Cys-74 of the TCR a constant region (Saito et al., 1984) and, in (B), Cys-92 of the TCR b constant
region (Gascoigne et al., 1984). The broken lines indicate the approximate boundary of the TM domain, defined using the Lasergene Navigator
Protean Software program (DNASTAR, Inc., Madison, WI).
focused on the CP, TM, and Cyto domains of the TCR antigen (DiGiusto and Palmer, 1994), to generate chime-
ric TCRs. These chimeric constructs (Figure 1) wereconstant regions. We show here that chimeric TCRs
containing d instead of a residues in the extracellular introduced into a TCR-negative murine T hybridoma
(58hCD4), and the resulting hybridoma cells were as-CP domain do not trigger IL-2 production in response
to antigenic ligands. The response to anti–TCR complex sayed for TCR expression levels. Out of 24 possible
combinations of chimeric TCRs, 21 were expressed atmonoclonal antibodies (MAbs) is not affected in these
chimeric TCRs, indicating that the TCR a chain CP do- the cell surface, as determined by fluorescence-acti-
vated cell sorting (FACS) techniques (Figure 2). Impor-main regulates the transduction of signals from anti-
genic but not cross-linking ligands. That a calcium iono- tantly, the relative surface expression of CD3e epitopes
(Figure 2) in comparison with Va2.1, Vb8.1, and Cb epi-phore restores the response to superantigen indicates a
defective calcium-mediated signaling pathway in these topes (data not shown) was not altered inchimeric TCRs.
This showed that the exchange of a with d and b withmutant chimeric TCRs. Finally, an evolutionary compari-
son of TCR a chain sequences in the CP domain reveals g TCR sequences did not influence the distal epitopes
recognized by these MAbs. While the wild-type a (awt)a conserved motif, FETDxNLN. Mutations within this
motif rendered the corresponding receptors unrespon- and the aI and aII chimeric chains were expressed at
sive to superantigen. Therefore, the FETDxNLN motif is the cell surface with the wild-type b (bwt) chain, the aIII,
required for the transduction of signals delivered by aIV, and aV chimeras (containing TCR d sequences in
physiological ligands. the CP domain) were not (Figure 2). The aIII, aIV, and
aV chimeras could be expressed to some degree at the
Results cell surface by pairing them with the chimeric bI chain
containing TCR g cytoplasmic residues (Figures 1 and
2). Wild-type expression levels of the TCR aIII–aV chainsExtracellular and Intracellular Domains of
the TCR ab Constant Regions Required were achieved by pairing them with a chimeric b chain
containing TM and Cyto TCR g sequences (Figure 2,for Cell Surface Expression
We used the 3BBM74 TCR, specific for the I-Abm12 alloan- e.g., aIII–aV/bIII). Taken together, these results showed
that introducing d sequences in the TCR a chain CPtigen and the Staphylococcal enterotoxinB (SEB) super-
TCR a Chain Constant Region Motif Required for Signaling
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Figure 2. Expression of the TCR Complex
Derived from Chimeric TCR a and b Chains
The 58hCD4 T hybridoma cells expressing
chimeric TCR a-d chains (shown to the left)
and chimeric TCR b-g chains (shown at the
top) were incubated with the fluorescein-con-
jugatedanti-CD3e MAb 145-2c11. Control au-
tofluorescence in each panel was detected
by incubating cells without MAb. Cells were
then analyzed by flow cytometry, and the re-
sults wereexpressed as the log10 relative fluo-
rescence versus cell number. The broken ver-
tical lines indicate the mean fluorescence
intensity of 58hCD4 cells expressing the wild-
type ab TCR. Similar results were obtained
using anti-Va2.1, anti-Vb8.1, or anti-Cb-spe-
cific MAbs (data not shown).
domain prevented cell surface expression with bwt bwt, aII/bwt, and aII/bIII. This unresponsiveness was not
due to low TCR expression, since all SEB-unresponsivechains (Figure 2, e.g., compare aII/bwt with aIII–aV/bwt).
Cell surface expression of these chimeras, however, hybridomas expressed similar numbers of TCRs (Figure
2). Comparing the TCR sequences of the SEB-respon-was restored by pairing them with a chimeric b chain
containing TCR g sequences within the Cyto domain sive chimera aII/bIII with those of the SEB-unresponsive
chimeras (aIII–aV/bIII) showed that the signaling-defec-(Figure 2, e.g., compare aIII–aV/bwt with aIII–aV/bI).
The awt chain was expressed at higher levels when tive chimeras all contained TCR d sequences in the CP
domain (Figures 1 and 3A). These data indicated thatpaired with the bIII chimera than with the bwt chain
(Figure 2, e.g., compare awt/bwt with awt/bIII). There- the extracellular CP domain of the TCR a chain constant
region must be intact to transmit signals delivered byfore, it appears that the TM domain of TCR g was more
efficient than that of TCR b for surface TCR expression. SEB. The replacement of the a and b TM and Cyto
domains with homologous TCR d and g domains byOn the other hand, the TM domains of the TCR a and
d chains were equivalent for surface expression when itself did not seem to affect reactivity to SEB, since a
hybridoma expressing the aII/bIII chimera respondedpaired with bwt chains (Figure 2, e.g., compare awt/bwt
with aII/bwt). Since the a chain CP domain was involved to SEB (Figure 3A). T hybridomas expressing chimeric
TCRs containing an altered a chain CP domain and TCRin TCR assembly and surface expression, we examined
the signaling properties of chimeric TCRs carrying alter- transgenic mice expressing the chimeric aIII/bIII TCR
were all unresponsive to the I-Abm12 alloantigen (B. T. B.,ations in this domain.
B. Hausmann, A. P., and E. P., unpublished data). Thus,
this unresponsiveness is not limited to bacterial super-TCR a Chain CP Domain Required
for Antigen Responses antigens, but extends to MHC-encoded allo (peptide)
antigens as well. Chimeric TCRs were capable of trans-The chimeric aII/bwt and aII/bIII receptors showed a
dose-dependent IL-2 production in response to SEB ducing a signal through the TCR complex, as they all
responded to plate-bound anti-CD3e (145-2c11), anti-similar to that seen with the wild-type TCR (Figure 3A).
Surprisingly, the TCR chimeras aIII/bIII, aIV/bIII, and aV/ Va2 (B20.1), and anti-Vb8 (F23.1) MAbs (Figure 3B; data
not shown). Taken together, these data demonstratebIII were all >100-fold less responsive to SEB than awt/
Immunity
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Figure 3. Response of Chimeric TCRs to SEB and MAbs Specific for CD3e or Thy-1
In each experiment, 5 3 104 58hCD4 cells per well expressing wild-type or chimeric TCRs were stimulated with 2 3 104 LG2 cells and increasing
doses of SEB (A), plate-bound anti-CD3e MAbs (B), or soluble anti-Thy-1 (C). Cultures were incubated for 24 hr, and supernatants were then
assayed for IL-2 concentration. Mouse recombinant IL-2 was used as a standard. Results shown are representative of two or more experiments.
that hybridomas expressing a modified TCR a chain CP tergent from hybridomas expressing antigen-respon-
sive TCRs (Figures 3A and 4A). In contrast, immuno-domain show impaired responses to antigenic ligands
(Figure 3A), while their responses to anti–TCR complex precipitations of antigen-unresponsive TCRs showed a
total absence of the z chain in Brij-97-containing butMAbs remain intact (Figure 3B).
Signaling through the Thy-1 molecule on T cells has not digitonin-containing cell lysates (Figures 3A and 4B).
The absence of z chains from signaling-defective TCRsbeen shown to be strictly dependent on the expression
of cell surface TCRs as well as functional z-z homodi- immunoprecipitated in Brij-97-containing buffer was
confirmed by Western blot analysis using the anti-z-mers (Gunter et al., 1987; Sussmann et al., 1988). The
Thy-1 signaling pathway was therefore examined in hy- specific MAb, G3 (data not shown). Since the z chain
could be coimmunoprecipitated with the TCR complexbridomas expressing wild-type or chimeric TCRs. All
hybridomas expressed comparable numbers of Thy-1 in digitonin lysates, the z chain was expressed at the cell
surface with the TCR in signaling-defective chimeras.molecules (data not shown). The wild-type and all chime-
ric TCRs tested responded similarly to Thy-1 stimulation However, the z chain association to the TCR complex
in these signaling-defective TCRs was altered, since(Figure 3C). Therefore, the ability to transmit a TCR–
and z chain–dependent signal through the Thy-1 mole- the z chain was not recovered from Brij-97-containing
lysates. Furthermore, fewer ab heterodimers were re-cule was not impaired in any of these hybridomas ex-
pressing chimeric TCRs. covered from these lysates as well (Figure 4B, compare
B lanes with D lanes), indicating that physical interac-
tions between the ab heterodimer and the CD3gde
Altered TCR–CD3/z Interactions in chains in antigen-unresponsive hybridomas was defec-
Antigen-Unresponsive Chimeric TCRs tive as well. Taken together, these data showed a corre-
Wild-type and chimeric TCRs were chemically labeled lation between the signaling-defective phenotype and
on the cell surface with biotin, and the TCR complex altered interactions among the TCR, CD3, and z chains.
was immunoprecipitated from digitonin- or Brij-97-con- Since one of the earliest indications of TCR triggering
is phosphorylation of the CD3e and z chains on tyrosinetaining cell lysates. Western blotting analysis showed
that the TCR ab heterodimer, CD3gde, and z chains were residues (Samelson et al., 1986), we investigated the
possibility that theblock insignal transduction after SEBall coimmunoprecipitated in the presence of either de-
TCR a Chain Constant Region Motif Required for Signaling
441
Figure 4. Immunoprecipitation and Western
Blot Analyses of Surface Biotinylated Cells
Expressing Chimeric TCRs
Surface biotinylated 58hCD4 cells expressing
wild-type or chimeric TCRs were lysed in 1%
Brij-97 (lanes marked B) or 1% digitonin
(lanes marked D) containing buffers, and the
TCR complex was immunoprecipitated with
anti-CD3e MAbs. (A) represents SEB-respon-
sive and (B) SEB-unresponsive chimeric
TCRs (data are from Figure 3A). Immunopre-
cipitates (107 cell equivalents per lane) were
analyzed by reducing 12% SDS–polyacryl-
amide gel electrophoresis followed by West-
ern blotting. Blots were probed with horse-
radish peroxidase–conjugated streptavidin
and developed using a chemiluminescence
detection system (Amersham). The positions
of the TCR ab, CD3gde, and z chains and
the relative positions of the molecular mass
standards (in kDa) are indicated.
stimulation (Figure 3A) was due to an absence of z chain could not be attributed to impaired z chain phosphoryla-
tion. Since antigen-unresponsive chimeric TCRs stillphosphorylation.
showed z chain phosphorylation after SEB stimulation,
another defect should account for the lack of IL-2 pro-Comparable z Chain Phosphorylation in
Antigen-Unresponsive Chimeric TCRs duction.
As a control, we first investigated z chain phosphoryla-
tion after CD3e stimulation. Hybridoma cells were stimu- Calcium Ionophore Rescues Signaling
in Antigen-Unresponsive TCRslated with anti-CD3e antibodies, and the TCR complex
was precipitated under conditions that preserved the We investigated whether the PKC- and calcium-medi-
ated signaling pathways were functioning in signaling-complete complex. The z chain was phosphorylated in
hybridoma cells expressing wild-type and chimeric defective TCRs. The 58hCD4 hybridoma expressing the
wild-type TCR showed no calcium mobilization uponTCRs (Figure 5), which was in agreement with their IL-2
responses (Figure 3B). Surprisingly, SEB induced z chain TCR cross-linking or superantigen stimulation (data not
shown; B.Malissen, personalcommunication).Wethere-phosphorylation in antigen-signaling (Figure 5A) as well
as in all antigen-nonsignaling TCR chimeras (Figure 5B). fore used a model of TCR-negative Jurkat cells tran-
siently transfected with a luciferase reporter constructAlthough the amount of z chain phosphorylation differed
among the chimeras, these differences did not correlate under the control of NF-AT and cDNAs encoding either
the wild-type or signaling-defective TCRs. In this way,with the signaling phenotype of the chimeric TCRs. For
example, theSEB-unresponsive chimera aV/bIII showed we could directly trace the stimulation of the TCR-
responsive element on the IL-2 promoter. The wild-typea slightly increased amount of phospho-zafter SEB stim-
ulation compared with the awt/bwt TCR (Figure 5). and mutant receptors responded similarly to TCR cross-
linking (data not shown). The data in Figure 6A showTherefore, the lack of SEB-induced IL-2 production
Figure 5. z Chain Phosphorylation of Anti-
CD3e- or SEB-Stimulated Hybridomas Ex-
pressing Chimeric TCRs
Hybridomas (58hCD4) expressing wild-type
or chimeric TCRs were stimulated with (50
mg/ml) orwithout anti-CD3e MAbs or with LG2
cells with (50 mg/ml) or without SEB. Cells
were lysed in 1% digitonin, and the TCR com-
plex was immunoprecipitated with anti-CD3e
MAbs. (A) represents SEB-responsive and (B)
SEB-unresponsive chimeric TCRs. Immuno-
precipitates (2 3 107 cell equivalents per lane)
were analyzed by 12% SDS–polyacrylamide
gel electrophoresis and immunoblotted with
the anti-phosphotyrosine MAb 4G10. The po-
sitions of phosphorylated z chains and immu-
noglobulin light chain (IgL) from the precipi-
tating MAb and the relative positions of the
molecular mass standards (in kDa) are indi-
cated.
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Figure 6. Effects of Calcium Ionophore and
PMA on Superantigen Stimulation
(A) The TCR-negative Jurkat cell line 31.13
was transfected with plasmids encoding
the wild-type or the aIV/bIII chimeric TCRs
and the NF-AT–luciferase reporter plasmid,
rested for 22 hr, and then activated. Cells
(6 3 106) were incubated with 106 LG2 cells
preloaded with (10 mg/ml) or without SEB.
The ionophore A23187 and the phorbol ester
PMA were used at final concentrations of 100
ng/ml and 10 ng/ml, respectively. After 8 hr of
incubation, luciferase activity of cell extracts
was measured and expressed as relative light
units. Cells transfected with the wild-type re-
ceptor showed a 1.2- to 3.6-fold increased
response to SEB in the presence of A23187
(data not shown), whereas the antigen-non-
signaling TCR showed a consistently larger
increase (4.4- to 8.3-fold). The graph is repre-
sentative of four different experiments, and
the error bars show calculated standard devi-
ations.
(B) The 58hCD4 hybridoma (5 3 104 cells per
well) expressing wild-type or chimeric TCRs
were stimulated with 2 3 104 LG2 cells and
a combination of 3 mg/ml SEB and 100 ng/
ml A23187 or 30 ng/ml PMA. Cultures were
incubated for 24 hr, and supernatants were
then assayed for IL-3 concentration. Mouse
recombinant IL-3 was used as a standard.
that Jurkat cells expressing the aIV/bIII TCR did not The Conserved Connecting Peptide Motif
FETDxNLN Is Required foractivate the NF-AT–luciferase reporter construct upon
stimulation with SEB. Interestingly, the calcium iono- Antigen-Induced Signaling
A motif consisting of the amino acids F101ETDxNLN108phore A23187 rescued the response to SEB, while phor-
bol-12-myristate-13-acetate (PMA) did not. The recov- emerged upon amino acid sequence comparison of the
TCR a chain CP domains among various species (Figureery of the SEB response by A23187 but not PMA
suggests that the chimeric TCR is defective in inducing 7A). The amino acid sequence identity among mammals
in the a chain CP domain (Cys-74to Asn-111) is relativelycalcium mobilization but is still capable of delivering an
adequate signal to the Ras–PKC pathway. This rescued high (71%) in comparison with mammalian TCR d chains,
which show only 50% identity (Campbell et al., 1994).SEB response also showed that the aIV/bIII TCR inter-
acted with SEB. The F101ETDxNLN108 motif is not present in the TCR d
chain CP domains, which share only one conservedSimilar results were obtained with the murine hybrid-
oma 58hCD4, expressing wild-type or mutant TCRs (Fig- amino acid (Asn-108) with the a chains in this region.
Interestingly, all signaling-defective chimeric TCRs ex-ure 6B). Whereas the wild-type TCR responded to SEB
and to a combination of SEB and PMA, the mutant TCR pressed an a chain with a damaged FETDxNLN motif
(Figures 1, 3, and 7). In two a-d chimeras (aIV and aV),aV/bIII did not. Although both hybridomas responded
somewhat to the calcium ionophore A23187 alone, they the FETDxNLN motif was eliminated (except for Asn-
108), whereas one chimeric a chain (aIII) expressed aboth showed an indistinguishable and elevated IL-3 re-
sponse to SEB in the presence of this ionophore. Similar disrupted motif. Altering or eliminating this motif in the
TCR a chain CP domain might interfere with antigenresults were seen for IL-2 (data not shown). These data
together showed that two different responses (IL-2 and responsiveness.
To test this hypothesis, we introduced mutationsIL-3) of two different signaling-defective receptors (aV/
bIII and aIV/bIII) could be rescued by the calcium iono- within the FETDxNLN motif in the ab TCR and assessed
the signaling capacity of these mutant receptors. T hy-phore A23187, both in a transient transfection assay
using Jurkat cells (Figure 6A) and in murine hybridomas bridomas expressing TCR a chains with substitution of
Asn-106 and Leu-107 to the homologous TCR d chainstably expressing these receptors (Figure 6B).
TCR a Chain Constant Region Motif Required for Signaling
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Figure 7. Sequence Comparison of the TCR
a and d Chain CP Domains in Different
Species
(A) Sequences of the CP domains from differ-
ent species (Campbell et al., 1994) are shown,
using the single-letter amino acid code. Se-
quences were aligned using the Lasergene
Navigator MegAlign Software program (Clus-
tal alignment method with the PAM250 resi-
due weight table). The FETDxNLN motif is
present in the TCR a chain CP domains
among all species displayed. Residues within
black boxes indicate sequence identity,
whereas residues within gray boxes are
charged.
(B) The 58hCD4 hybridoma expressing the
wild-type TCR b chain and wild-type or mu-
tant TCR a chains were tested for super-
antigen reactivity as described in Figure 3.
Results shown are representative of three ex-
periments.
amino acids lysine and valine, respectively, were clearly this domain do not affect T cell activation upon receptor
cross-linking with anti-Va2.1, anti-Vb8.1, or anti-CD3eless responsive to SEB than the wild-type ab TCR (Fig-
ure 7B). The replacement of Glu-102, Asp-104, and Asn- MAbs (Figure 3B; data not shown). Thus, TCRs with an
altered a chain CP domain are specifically defective in106 with alanine residues generated a TCR that required
100-fold more SEB than the wild type to produce similar transmitting signals from antigenic ligands.
Immunoprecipitates of TCR complexes carrying aamounts of IL-2. Furthermore, substitution of the amino
acids Phe-109, Gln-110, and Asn-111 located outside substituted TCR a chain CP domain contain z chains
in the presence of digitonin-containing but not Brij-97-of this motif showed only a negligible effect on TCR
signaling. All mutant TCRs were expressed on the cell containing buffers (Figure 4). This indicates that z chains
are present within the TCR complex from signaling-surface at levels similar to that of wild-type TCR (data
not shown). Therefore, modifying amino acids within, defective TCRs. However, the interactions between the
TCR and the CD3/z complex in these signaling-defectivebut not outside of, this TCR a chain connecting peptide
motif significantly diminished the response to SEB. chimeric TCRs are clearly altered. Although antigen-
unresponsive chimeras induce z chain phosphorylation
after superantigen stimulation (Figure 5), these chimericDiscussion
TCRs do not generate a full signal resulting in the pro-
duction of IL-2 (Figure 3A). The signaling status of theseThis report implicates the TCRCP domain in transmitting
defective TCRs is reminiscent of the signals producedsignals from antigenic ligands. To determine which do-
by altered peptide ligands (Sloan-Lancaster et al., 1994;mains in the TCR constant regions are important for
Madrenas et al., 1995). Antagonists and partial agoniststransmitting signals from the ab heterodimer to the
are generally capable of inducing some degree of z chainCD3/z complex, we generated chimeric TCRs and stud-
phosphorylation, but not IL-2 production. Whereas ago-ied their ability to respond to various stimuli. We found
nist peptides induce z chain phosphorylation yielding athat chimeric TCRs containing a substituted a chain CP
pp21 and pp23 form, antagonist ligands produce pre-domain are unresponsive to alloantigens and superanti-
gens (Figure 3; data not shown). Surprisingly, changes in dominantly the pp21 form (Sloan-Lancaster et al., 1994).
Immunity
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In the experiments shown in Figure 5, only one form of with this superantigen. Therefore, we favor the explana-
tion that the mutant TCRs still bind their ligands, but failphospho-z was detected upon stimulation in hybrido-
to transmit a complete signal to the CD3/z complex.mas expressing wild-type or chimeric TCRs. This may
It has been suggested that the TCR and CD4 interactbe a property of the 58hCD4 recipient cell line. Further-
in a defined way and that physical association betweenmore, T cells stimulated with antagonist ligands recruit
the TCR and CD4 is necessary for the release of storedZAP-70 to the TCR complex, but it remains unphosphor-
intracellular calcium and optimal T cell activation (Dian-ylated (Madrenaset al., 1995). These results indicate that
zani et al., 1992; Wolff et al., 1993). Our antigen-unre-recruitment and phosphorylation of ZAP-70 is crucial for
sponsive TCRs may fail to deliver a full signal if theT cell activation. Since signaling-defective TCR chime-
TCR a chain CP domain is involved in the interactionras still induce z chain phosphorylation, the block in
with CD4.signal transduction could be due to the absence of ZAP-
The conserved motif, F101ETDxNLN108, emerged upon70 recruitment or phosphorylation. Experiments investi-
sequence comparison of TCR a chain CP domains fromgating the function of ZAP-70 with these TCR chimeras
different species (Figure 7A). All signaling-defective chi-have been uninformative because the amount of phos-
meric TCRs express a chains where this motif has beenphorylated ZAP-70 produced in mouse T cell hybrido-
eliminated or disrupted (Figure 1). Substitutions of themas is below the sensitivity of detection using the
Glu-102-Asp-104-Asn-106 residues in the TCR a chainreagents currently available (R. Germain, personal com-
connecting peptide motif abrogated antigen reactivity,munication; B. T. B. and E. P., unpublished data).
while mutations of Phe-109, Gln-110, and Asn-111 (out-The experiments shown in Figure 6 indicate that anti-
side the motif) only negligibly affected antigen respon-gen-unresponsive TCRs are defective in generating cal-
siveness (Figure 7B). Therefore, specific alterations ofcium-mediated signals. The wild-type receptor re-
the F101ETDxNLN108 motif within the context of an other-sponds to SEB, whereas SEB activation through the
wise wild-type TCR lead to an antigen-specific signal-antigen-unresponsive TCR is impaired. Interestingly,
ing-defective phenotype. Certain residues in theSEB responsiveness by signaling-defective TCRs could
FETDxNLN motif are required for expression, while oth-be rescued with the calcium ionophore A23187. That a
ers allow for the transmission of antigenic signalscalcium ionophore restores the SEB response of the
(B. T. B., A. P., and E. P., unpublished data). We proposenonsignaling TCR to wild-type levels indicates that the
to name this TCR motif the a chain connecting peptidereceptor defect may be due to inadequate signaling
motif (a-CPM).through the calcium-mediated signaling pathway. In
In summary, we have shown that the TCR a chain CPcontrast, PMA does not rescue the response to SEB,
domain is required for antigen responsiveness, TCR cellimplying that signaling through the Ras–PKC pathway
surface expression, and interactions with the CD3/zis not deficient in cells expressing the mutant TCR (Bald-
complex. A sequence comparison of the a chain CPari et al., 1993; Downward et al., 1990; Rayter et al.,
domains among different species reveals a conserved1992).
motif (a-CPM) whose intact structure is required forWegener et al. (1992) have reported that the TCR com-
transducing signals from antigenic ligands to T lympho-plex is composed of two parallel signal-transducing
cytes.modules, specifically CD3gde and z-z. These modules
might be involved in two distinct but partially overlap-
Experimental Procedures
ping signaling pathways, as suggested by Isakov et al.
(1994). Since SEB induces z chain phosphorylation but DNA Constructs
The Va2.1 and Vb8.1 TCR cDNAs were isolated from the T cellnot IL-2 production, it is conceivable that the antigen-
hybridoma, 3BBM74, and confer reactivity to the I-Abm12 alloantigenunresponsive chimeras fail toactivate theCD3gde-trans-
and the SEB superantigen (DiGiusto and Palmer, 1994). The cDNAsducing module. Our results demonstrate a weaker as-
encoding the wild-type a chain or a-d chimeras were constructed
sociation between the ab heterodimer and the CD3 using the 3BBM74 a chain and Cd cDNAs (Chien et al., 1987), over-
complex in these mutant TCRs (Figure 4), and this defec- lapping oligonucleotides, and the polymerase chain reaction and
tive interaction may not allow for activation of the cal- then cloned into the retroviral expression vector LXSN (Miller and
Rosman, 1989; Mullen et al., 1992). Similarly, cDNAs encoding thecium-mediated signaling pathway (Figure 6).
wild-type b chain or b-g chimeras were constructed using theOne possible explanation for the antigen unrespon-
3BBM74 b chain and Cg1 cDNAs (Hayday et al., 1985b), overlapping
siveness observed in hybridomas expressing thechime- oligonucleotides, and the polymerase chain reaction and then
ric TCRs (Figure 3A) is that the disruption of TCR a chain cloned into the retroviral vector LXSP. The LXSP vector was gener-
sequences in the CP domain generates a receptor that ated by replacing the BamHI–XbaI fragment encoding the neomycin
resistance gene in LXSN with the BamHI–XbaI fragment from thecan no longer bind its ligand. If this were the case,
pBABE Puro vector (Morgenstern and Land, 1990), which containsthen the a chain CP domain might indirectly affect the
a puromycin resistance gene (L. Ellis and E. P., unpublisheddata). Allstructure of the peptide–MHC binding site and the affin-
constructs were verified by DNA sequencing using the SequiTherm
ity of the TCR for its antigen. Although this would be cycle sequencing kit (Epicentre Technols., Madison, WI). The de-
an interesting possibility, it seems unlikely, since SEB duced amino acid sequences of the a-d and b-g chimeras are shown
in Figure 1.induces z chain phosphorylation in all chimeric TCRs
The NF-AT–luciferase reporter plasmid was constructed by sub-tested (Figure 5). This indicates that antigen-unrespon-
cloning a 200 bp NF-AT–CAT fragment containing the NF-AT syn-sive TCRs bind this superantigen and that some signal-
thetic promoter (Emmel et al., 1989) purified after digestion with
ing functions are still intact. That the calcium ionophore Asp-718, filling with Klenow polymerase, and subsequent digestion
A23187 rescues the response to SEB (Figure 6) also with HindIII between the SmaI and HindIII sites of pUBTluc (de-
Martin et al., 1993).indicates that the antigen-unresponsive TCRs interact
TCR a Chain Constant Region Motif Required for Signaling
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Cell Lines concentration of SEB (Toxin Tech., Sarasota, FL) in triplicate wells
(total of 200 ml per well). For anti-TCR MAb-specific responses,The a2b2 T hybridoma, 58, has been described previously (Letour-
neur and Malissen, 1989). The 58hCD4 cell line was produced by various concentrations of the indicated MAb in PBS were incubated
overnight at 48C in 96-well flat-bottom plates (Costar, Cambridge,introducing human CD4 cDNA into the 58 T hybridoma using the
mycophenolic acid resistance marker (O. Acuto, Institut Pasteur, MA). Wells were then rinsed three times with 200 ml of PBS, and
5 3 104 T hybridoma cells in 200 ml of complete IMDM were addedParis, personal communication). The human B cell line LG2 (Accolla,
1984) expressing MHC class II DR1 molecules, a gift from A. Lanza- to triplicate wells. After 20–24 hr at 378C, supernatants were removed
and frozen at 2208C until use. IL-2 was assayed by incubating 2 3vecchia (Basel Institute for Immunology), was utilized to present the
superantigen SEB. Infectious retroviral stocks were generated using 103 HT-2 cells and IL-3 was assayed by incubating 2 3 103 FDC-P1
cells per well in round-bottom 96-well plates with serial dilutions ofthe packing line GP1E-86 (Markowitz et al., 1988). All cell lines were
grown in Iscove’s modified Dulbecco’s medium (IMDM) supple- culture supernatants. Alamar blue substrate (Alamar Biosciences,
Sacramento, CA) was added after 16–24 hr of incubation to HT-2mented with 5% fetal calf serum (FCS), 2 mM glutamine, 2.3 mM
b-mercaptoethanol, 100 IU/ml penicillin, 100 mg/ml streptomycin, and after 48 hr to FDC-P1 cells, and the relative number of surviving
cells was determined 24–48 hr later according to the instructionsand 50 mg/ml gentamicin (complete IMDM). The indicator cell lines
HT-2 (Watson, 1979) and FDC-P1 (Dexter et al., 1980) were grown of the manufacturer. Recombinant murine IL-2 (Pharmingen, San
Diego, CA) and IL-3 (Genzyme, Cambridge, MA) were used as ain the above-mentioned medium with the addition of 25 U/ml IL-2
or 1000 U/ml IL-3, respectively. The TCR-negative Jurkat subline standard, and the concentration of IL-2 and IL-3 in experimental
cultures was calculated using the SOFTmax 2.32 software.31.13 (Alcover et al., 1988) was maintained in RPMI supplemented
with 10% FCS and the above-mentioned additives.
Cell Surface Biotinylation AnalysisAntibodies
Immunodetection of surface biotinylated proteins was carried outThe anti-Va2.1-specific MAb B20.1 (Necker et al., 1991), the anti-
using similar conditions as described by Meier et al. (1992). In brief,Vb8.1 MAb F23.1 (Staerz et al., 1985), and the anti-CD3e MAb 145-
2 3 107 cells were resuspended in 1 ml of carbonate buffer (25 mM2c11 (Leo et al., 1987) were purified from culture supernatants using
NaHCO3, 150 mM NaCl, 1 mM MgCl2 [pH 8.3]) containing 100 mg/protein G (Pharmacia, Uppsala, Sweden). The anti–z chain MAb G3
ml Sulfo-NHS-biotin (Pierce, Rockford, IL). Cells were incubated for(van Oers et al., 1994) was a gift of N. van Oers (University of Califor-
10 min at room temperature, washed once with PBS containing 25nia, San Francisco), and the anti-Thy-1 MAb G7 (Gunter et al., 1984)
mM lysine and 2% FCS, and once with PBS. Surface biotinylatedwas provided by F. Letourneur (Basel Institute for Immunology). The
cells were lysed at 5 3 107 cells per milliliter in 1% Brij-97 (Sigma)anti-phosphotyrosine MAb 4G10 was purchased from UBI (Lake
or 1% digitonin (Sigma) lysis buffers (20 mM Tris–HCl [pH 7.5], 150Placid, NY).
mM NaCl, 5 mM EDTA, 1 mM PMSF, 10 mg/ml leupeptin, and 10
mg/ml aprotinin) for 15–20 min at room temperature. Lysates wereGeneration of Retroviral Supernatants and Infection
centrifuged at 12,000 3 g for 10 min, and the supernatants wereof T Hybridomas
then incubated for 2 hr at room temperature with 2 mg of anti-CD3eRetroviruses encoding the chimeric TCR chains were generated
(145-2c11) that had been previously chemically cross-linked to 20according to the procedure of Chen and Okayama (1987) with minor
ml protein G–Sepharose beads (Harlow and Lane, 1988). The beads
changes. In brief, GP1E-86 cells were plated at 5 3 105 cells in a
were then washed twice with lysis buffer containing 0.2% Brij-97
T75 flask in complete IMDM and incubated overnight. Then 10 mg
or 0.2% digitonin and once with lysis buffer without detergents.
of plasmid DNA in 1 ml of calcium phosphate solution was added
Precipitated proteins were eluted with 100 ml of 1% formic acid
to the cells. After a further 16 hr incubation, cells were rinsed once
for 1 min and removed from the antibody-conjugated beads after
and then selected with complete IMDM containing 1 mg/ml G418
centrifugation (Pleiman et al., 1993). Formic acid was removed using
(GIBCO, Inchinnan, Scotland) or 3 mg/ml puromycin (Sigma Chemie,
a SpeedVac concentrator, and samples were resuspended in 20 ml
Buchs, Switzerland) for transfections with the LXSN or LXSP vec-
of SDS reducing sample buffer. Immunoprecipitated proteins were
tors, respectively. Virus-containing supernatants from drug-resis-
resolved on 12% SDS–polyacrylamide gel using the Bio-Rad Mini-
tant pools of GP1E-86 cellswere collected from confluent cell layers
Gel system (Mountainview, CA). Proteins were then transferred at
after 7–10 days. Selective medium was replaced with complete
200 mA to polyvinylidene difluoride membranes (Bio-Rad) in Towbin
IMDM 8–16 hr prior to harvest, passed through 0.45 mm filters, and
buffer (25 mM Tris base, 192 mM glycine) containing 15% methanol
stored at 2708C.
and 0.005% SDS for 30 min. Membranes were blocked with 5%T hybridoma cells (5 3 105) were infected with 1 ml of supernatant,
nonfat milk (Bio-Rad) in PBS containing 0.4% Tween 20 for 1 hr andcontaining viruses encoding bwt or b-g chimeric constructs, in the
then incubated with a 1:50,000 dilution of horseradish peroxidase–presence of 4 mg/ml Polybrene (Sigma). Virus-containing superna-
conjugated streptavidin (Southern Biotechnology Associates, Bir-tants were replaced with complete IMDM after a 4 hr incubation
mingham, AL). Proteins were detected using a chemiluminescence
at 378C. After a further 16 hr of incubation, puromycin at a final
detection system (Amersham, Buckinghamshire, United Kingdom).
concentration of 3 mg/ml was added, and cultures were maintained
under selection for 7–10 days. Puromycin-resistant cells expressing
bwt chains or b-g chimeric chains were subsequently infected with z Chain Tyrosine Phosphorylation Analysis
viruses encoding TCR awt or a-d chimeric cDNAs and selected For anti-CD3e stimulation, 2 3 107 T hybridoma cells were resus-
with 1 mg/ml of G418. After selection, cells were then used for pended at 5 3 107 cells per milliliter in serum-free IMDM and incu-
experiments within 2 weeks. bated with soluble 145-2c11 (50 mg/ml) for 30 min on ice. For super-
antigen stimulation, LG2 antigen-presenting cells were incubated
Flow Cytometry Analysis at 5 3 107 cells per milliliter with or without SEB (50 mg/ml) for 2 hr
The level of TCR expression was determined on cells incubated with in complete IMDM. Cells were thenwashed with serum-free medium,
saturating concentrations of biotinylated B20.1 (anti-Va2.1 MAb) or and 2 3 107 LG2 cells were added to 2 3 107 T hybridoma cells in
biotinylated F23.1 (anti-Vb8.1 MAb) and streptavidin–phycoerythrin a 6-well plate. After a short centrifugation (2200 rpm for 5 s), cultures
or fluoresceinated 145-2c11 (anti-CD3e MAb) in 50 ml of PBS con- were incubated at 378C for 20 min. Anti-CD3e- and SEB-stimulated
taining 2% FCS and 0.1% azide. Fluoresceinated T24-31.7 MAb was cells were washed twice with ice-cold PBS containing 1 mM Na3VO4
used to determine Thy-1 expression levels. Cells were analyzed on and then lysed in lysis buffer (20 mM Tris–HCl [pH 7.5], 150 mM
a FACScan (Becton Dickinson), and dead cells were excluded using NaCl, 5 mM EDTA, 1 mM PMSF, 10 mg/ml leupeptin, and 10 mg/ml
0.2 mg/ml propidium iodide. Results were analyzed using the Lysys aprotinin) containing 1 mM Na3VO4, 25 mM NaF, and 1% digitonin.
II software. After 20 min on ice, lysates were centrifuged at 12,000 3 g for 10
min, and the TCR complex was immunoprecipitated by adding 1.5
mg of 145-2c11 MAb and 20 ml of protein G–Sepharose to the super-T Cell Stimulation and IL-2 and IL-3 Assays
Superantigen-specific responses were assayed by incubating 5 3 natants. Samples were incubated for 2 hr at 48C, washed twice with
lysis buffer containing 1 mM Na3VO4, 25 mM NaF, and 0.2% digitonin104 T hybridoma cells and 2 3 104 LG2-presenting cells with various
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and once with the same buffer without detergent. Immunoprecipi- Ashwell, J.D., and Klausner, R.D. (1990). Genetic and mutational
analysis of the T-cell antigen receptor. Annu. Rev. Immunol. 8,tates were then electrophoresed on 12% SDS–polyacrylamide gel
and transferred to polyvinylidene difluoride membranes, as de- 139–167.
scribed above. The membranes were blocked in 5% nonfat milk Baldari, C.T., Heguy, A., and Telford, J.L. (1993). ras protein activity
(Bio-Rad) in TBST (20 mM Tris–HCl [pH 8.0], 150 mM NaCl, 0.4% is essential for T-cell antigen receptor signal transduction. J. Biol.
Tween 20) for 1 hr at 378C. The blots were then incubated for 1.5 Chem. 268, 2693–2698.
hr at room temperature with the anti-phosphotyrosine MAb 4G10
Campbell, K.S., Ba¨ckstro¨m, B.T., Tiefenthaler, G., and Palmer, E.
(75 ng/ml), washed twice for 5 min with TBST, and incubated with a
(1994). CART: a conserved antigen receptor transmembrane motif.
1:25,000 dilution of goat anti–mouse IgG conjugated to horseradish
Semin. Immunol. 6, 393–410.
peroxidase (Bio-Rad) for 30 min at room temperature. The mem-
Chan, A.C., Desai, D.M., and Weiss, A. (1994). The role of proteinbranes were then washed twice for 5 min with TBST, once with TBS
tyrosine kinases and protein tyrosine phosphatases in T cell antigen(TBST without Tween 20), and subsequently developed using the
receptor signal transduction. Annu. Rev. Immunol. 12, 555–592.chemiluminescence detection system (Amersham).
Chen, C., and Okayama, H. (1987). High-efficiency transformation
of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745–2752.Transfection, Stimulation, and NF-AT Activity
Chien, Y.-h., Iwashima, M., Kaplan, K.B., Elliott, J.F., and Davis,The TCR-negative Jurkat subline 31.13 (Alcover et al., 1988) was
M.M. (1987). A new T cell receptor gene located within the a locustransiently transfected using a modification of the DEAE–dextran
and expressed early in T cell differentiation. Nature 327, 677–682.procedure, as previously described (Baldari et al., 1993). For each
sample, 0.5 mg of NF-AT–luciferase reporter plasmid and 0.8 mg Clevers, H., Alarcon, B., Willeman, T., and Terhorst, C. (1988). The
each of TCR awt and bwt cDNAs or the chimeric aIV and bIII cDNAs T cell receptor/CD3 complex: a dynamic protein ensemble. Annu.
were used. To minimize variability among samples, activation was Rev. Immunol. 6, 629–662.
carried out on aliquots of single pools of transfected cells in dupli- de-Martin, R., Strasswimmer, J., and Philipson, L. (1993). A new
cate. Cells were allowed to recover for 22 hr after transfection. luciferase promoter insertion vector for the analysis of weak tran-
Activation by cross-linking the Vb8.1 TCR was carried out by incuba- scriptional activities. Gene 124, 137–138.
tion of 3 3 106 to 6 3 106 cells with 20 mg/ml F23 MAb for 30 min
Dexter, T.M., Garland, J., Scott, D., Scolnick, E., and Metcalf, D.at 48C, which were then washed once, transferred to 6-well plates
(1980). Growth of factor-dependenthemopoietic precursorcell lines.that had been precoated overnight with 1 ml of 50 mg/ml anti-mouse
J. Exp. Med. 152, 1036–1047.MAb (Cappel, West Chester, PA) at 48C, and blocked for 1 hr with
Dianzani, U., Shaw, A., al-Ramadi, B.K., Kubo, R.T., and Janeway,RPMI containing 10% FCS at 378C. Activation by superantigen was
C., Jr. (1992). Physical association of CD4 with the T cell receptor.carried out by adding 6 3 106 transfected cells to 106 LG2 cells
J. Immunol. 148, 678–688.preincubated with 10 mg/ml SEB for 2 hr at 378C in 6-well plates.
At 8 hr postactivation, cellswere collected by centrifugation, washed DiGiusto, D.L., and Palmer, E. (1994). An analysis of sequence varia-
once with PBS, and tested for luciferase activity using a kit from tion in the b chain framework and complementarity determining
Promega (Madison, WI) and a BioOrbit 1253 luminometer. The lucif- regions of an allo-reactive T cell receptor. Mol. Immunol. 31,
erase values were normalized to protein concentrations in the cell 693–699.
extracts and to transfection efficiency, measured by TCR-indepen- Downward, J., Graves, J.D., Warne, P.H., Rayter, S., and Cantrell,
dent maximal activation by a combination of 10 ng/ml PMA (Sigma) D.A. (1990). Stimulation of p21ras upon T-cell activation. Nature346,
and 100 ng/ml ionophore A23187 (Boehringer Mannheim AG, Swit- 719–723.
zerland).
Emmel, E.A., Verweij, C.L., Durand, D.B., Higgins, K.M., Lacy, E., and
Crabtree, G.R. (1989). Cyclosporin A specifically inhibits function of
Acknowledgments nuclear proteins involved in T cell activation. Science 246, 1617–
1620.
Correspondence should be addressed to B. T. B. or E. P. (Palmer@ Evavold, B.D., Sloan-Lancaster, J., and Allen, P.M. (1993). Tickling
bii.ch). We thank Sabine Stotz and Virginia Appel for generating the TCR: selective T-cell functions stimulated by altered peptide
chimeric constructs, Barbara Hausmann for technical assistance, ligands. Immunol. Today 14, 602–609.
Mark Dessing for advice with FACS experiments, and Drs. Nicolai
Finkel, T.H., Kubo, R.T., and Cambier, J.C. (1991). T-cell develop-van Oers and Franc¸ois Letourneur for the generous gift of MAbs.
ment and transmembrane signaling: changing biological responsesThe authors also thank our colleagues Drs. Luca Bolliger, Jean-
through an unchanging receptor. Immunol. Today 12, 79–85.Marie Bu¨rstedde, Kerry Campbell, Johann Frey, Thomas Go¨bel,
Gascoigne, N.R.J., Chien, Y.-h., Becker, D.M., Kavaler, J., and Davis,Wayne Hein, Klaus Karjalainen, Pawel Kisielow, Antonio Lanzavec-
M.M. (1984). Genomic organization and sequence of T cell receptorchia, Franc¸ois Letourneur, Antonius Rolink, John Telford, and Savla-
b chain constant and joining region genes. Nature 310, 387–391.tore Valitutti for discussion, Ms. Cynthia Teo-Geiger for preparation
of the manuscript, and Beatrice Pfeiffer for photography. The gener- Gunter, K.C., Malek, T.R., and Shevach, E.M. (1984). T cell-activating
ous financial support of Telethon–Italy (grant E.207), the Italian Asso- properties of an anti-Thy-1 monoclonal antibody: possible analogy
ciation for Cancer Research (AIRC), and the Istituto Superiore di to OKT3/Leu-4. J. Exp. Med. 159, 716–730.
Sanita’ (AIDS Project) is gratefully acknowledged. E. M. is the recipi- Gunter, K.C., Germain, R.N., Kroczek, R.A., Saito, T., Yokoyama,
ent of a fellowship from AIRC. The Basel Institute for Immunology W.M., Chan, C., Weiss, A., and Shevach, E.M. (1987). Thy-1-medi-
was foundedand is supported by F. Hoffmann–La Roche LTD,Basel, ated T-cell activation requires co-expression of CD3/Ti complex.
Switzerland. Nature 326, 505–507.
Haas, W., Pereira, P., and Tonegawa, S. (1993). g/d cells. Annu. Rev.Received April 16, 1996; revised August 19, 1996.
Immunol. 11, 637–685.
Harlow, E., and Lane, D. (1988). Antibodies: A Laboratory ManualReferences
(Cold Spring Harbor, New York: Cold Spring Harbor Laboratory).
Hayday, A.C., Diamond, D.J., Tanigawa, G., Heilig, J.S., Folsom,Accolla, R.S. (1984). Analysis of the structural heterogeneity and
V., Saito, H., and Tonegawa, S. (1985a). Unusual organization andpolymorphism of human Ia antigens: four distinct subsets of mole-
diversity of T-cell receptor a-chain genes. Nature 316, 828–832.cules are coexpressed in the Ia pool of both DR1,1 homozygous
and DR3,W6 heterozygous B cell lines. J. Exp. Med. 159, 378–393. Hayday, A.C., Saito, H., Gillies, S.D., Kranz, D.M., Tanigawa, G.,
Eisen, H.N., and Tonegawa, S. (1985b). Structure, organization, andAlcover, A., Alberini, C., Acuto, O., Clayton, L.K., Transy, C., Spag-
somatic rearrangement of T cell g genes. Cell 40, 259–269.noli, G.C., Moingeon, P., Lopez, P., and Reinherz, E.L. (1988). Inter-
dependence of CD3-Ti and CD2 activation pathways in human T Isakov, N., Wange, R.L., and Samelson, L.E. (1994). The role of
tyrosine kinases and phosphotyrosine-containing recognition motifslymphocytes. EMBO J. 7, 1973–1977.
TCR a Chain Constant Region Motif Required for Signaling
447
in regulation of the T cell-antigen receptor-mediated signal trans- Tonegawa, S. (1984). A third rearranged and expressed gene in a
clone of cytotoxic T lymphocytes. Nature 312, 36–40.duction pathway. J. Leukoc. Biol. 55, 265–271.
Jameson, S.C., and Bevan, M.J. (1995). T cell receptor antagonists Samelson, L.E., Patel, M.D., Weissman, A.M., Harford, J.B., and
Klausner, R.D. (1986). Antigen activation of murine T cells inducesand partial agonists. Immunity 2, 1–11.
tyrosine phosphorylation of a polypeptide associated with the T cellKrangel, M.S., Bierer, B.E., Devlin, P., Clabby, M., Strominger, J.L.,
antigen receptor. Cell 46, 1083–1090.McLean, J., and Brenner, M.B. (1987). T3 glycoprotein is functional
although structurally distinct on human T-cell receptor g T lympho- Schild, H., Mavaddat, N., Litzenberger, C., Ehrich, E.W., Davis, M.M.,
Bluestone, J.A., Matis, L., Draper, R.K., and Chien, Y.H. (1994). Thecytes. Proc. Natl. Acad. Sci. USA 84, 3817–3821.
nature of major histocompatibility complex recognition by gd T cells.Leo, O., Foo, M., Sachs, D.H., Samelson, L.E., and Bluestone, J.A.
Cell 76, 29–37.(1987). Identification of a monoclonal antibody specific for a murine
T3 polypeptide. Proc. Natl. Acad. Sci. USA 84, 1374–1378. Sciammas, R., Johnson, R.M., Sperling, A.I., Brady, W., Linsley, P.S.,
Spear, P.G., Fitch, F.W., and Bluestone, J.A. (1994). Unique antigenLetourneur, F., and Malissen, B. (1989). Derivation of a T cell hybrid-
recognition by a herpesvirus-specific TCR-gd cell. J. Immunol. 152,oma variant deprived of functional T cell receptor a and b chain
5392–5397.transcripts reveals a nonfunctional a-mRNA of BW5147 origin. Eur.
J. Immunol. 19, 2269–2274. Serfling, E., Avots, A., and Neumann, M. (1995). The architecture of
the interleukin-2 promoter: a reflection of T lymphocyte activation.Madrenas, J., Wange, R.L., Wang, J.L., Isakov, N., Samelson, L.E.,
Biochim. Biophys. Acta 1263, 181–200.and Germain, R.N. (1995). z Phosphorylation without ZAP-70 activa-
tion induced by TCR antagonists or partial agonists. Science 267, Sette, A., Alexander, J., Ruppert, J., Snoke, K., Franco, A., Ishioka,
G., and Grey, H.M. (1994). Antigen analogs/MHC complexes as spe-515–518.
cific T cell receptor antagonists. Annu. Rev. Immunol. 12, 413–431.Malissen, B., and Schmitt-Verhulst, A.M. (1993). Transmembrane
signaling through the T-cell-receptor-CD3 complex. Curr. Opin. Im- Sloan-Lancaster, J., Shaw, A.S., Rothbard, J.B., and Allen, P.M.
(1994). Partial T cell signaling: altered phospho-z and lack of zap70munol. 5, 324–333.
recruitment in APL-induced T cell anergy. Cell 79, 913–922.Malissen, M., Minard, K., Mjolsness, S., Kroneberg, M., Goverman,
J., Hunkapiller, T., Prystowsky, M.B., Yoshikai, Y., Fitch, F., Mak, Staerz, U.D., Rammensee, H.G., Benedetto, J.D., and Bevan, M.J.
(1985). Characterization of a murine monoclonal antibody specificT.W., and Hood, L. (1984). Mouse T cell antigen receptor: structure
and organization of constant and joining segments encoding the b for an allotypic determinant on T cell antigen receptor. J. Immunol.
134, 3994–4000.polypeptide. Cell 37, 1101–1110.
Markowitz, D., Goff, S., and Bank, A. (1988). A safe packaging line Sussmann, J.J., Bonifacino, J.S., Lippincott, S.J., Weissman, A.M.,
Saito, T., Klausner, R.D., and Ashwell, J.D. (1988). Failure to synthe-for gene transfer: separating viral genes on two different plasmids.
J. Virol. 62, 1120–1124. size the T cell CD3-z chain: structure and function of a partial T cell
receptor complex. Cell 52, 85–95.Meier, T., Arni, S., Malarkannan, S., Poincelet, M., and Hoessli, D.
(1992). Immunodetection of biotinylated lymphocyte-surface pro- van Oers, N.S., Teh, S.J., Irving, B.A., Tiong, J., Weiss, A., and Teh,
H.S. (1994). Production and characterization of monoclonal antibod-teins by enhanced chemiluminescence: a nonradioactive method
for cell-surface protein analysis. Anal. Biochem. 204, 220–226. ies specific for the murine T cell receptor z chain. J. Immunol. Meth.
170, 261–268.Miller, A.D., and Rosman, G.J. (1989). Improved retroviral vectors
von Boehmer, H. (1994). Positive selection of lymphocytes. Cell 76,for gene transfer and expression. Biotechniques 7, 980–990.
219–228.Morgenstern, J.P., and Land, H. (1990). Advanced mammalian gene
Watson, J. (1979). Continuous proliferation of murine antigen-spe-transfer: high titre retroviral vectors with multiple drug selection
cific helper T lymphocytes in culture. J. Exp. Med. 150, 1510–1519.markers and a complementary helper-free packaging cell line. Nucl.
Acids Res. 18, 3587–3596. Wegener, A.M., Letourneur, F., Hoeveler, A., Brocker, T., Luton, F.,
and Malissen, B. (1992). The T cell receptor/CD3 complex is com-Mullen, C.A., Kilstrup, M., and Blaese, R.M. (1992). Transfer of the
posed of at least two autonomous transduction modules. Cell 68,bacterial gene for cytosine deaminase to mammalian cells confers
83–95.lethal sensitivity to 5-fluorocytosine: a negative selection system.
Proc. Natl. Acad. Sci. USA 89, 33–37. Weiss, A. (1991). Molecular and genetic insights into T cell antigen
receptor structure and function. Annu. Rev. Genet. 25, 487–510.Necker, A., Rebai, N., Matthes, M., Jouvin-Marche, E., Cazenave,
P.A., Swarnworawong, P., Palmer, E., MacDonald, H.R., and Malis- Weiss, A., and Littman, D.R. (1994). Signal transduction by lympho-
sen, B. (1991). Monoclonal antibodies raised against engineered cyte antigen receptors. Cell 76, 263–274.
soluble mouse T cell receptors and specific for Va8-, Vb2- or Vb10- Wolff, C.H., Hong, S.C., von-Grafenstein, H., and Janeway, C., Jr.
bearing T cells. Eur. J. Immunol. 21, 3035–3040. (1993). TCR-CD4 and TCR-TCR interactions as distinctive mecha-
Pleiman, C.M., Clark, M.R., Gauen, L.K., Winitz, S., Coggeshall, K.M., nisms for the induction of increased intracellular calcium in T-cell
Johnson, G.L., Shaw, A.S., and Cambier, J.C. (1993). Mapping of signaling. J. Immunol. 151, 1337–1345.
sites on the Src family protein tyrosine kinases p55blk, p59fyn, and Zenner, G., zur-Hausen, J.D., Burn, P., and Mustelin, T. (1995). To-
p56lyn which interact with the effector molecules phospholipase wards unraveling the complexity of T cell signal transduction. Bioes-
C-g2, microtubule-associated protein kinase, GTPase-activating says 17, 967–975.
protein, and phosphatidylinositol 3-kinase. Mol. Cell. Biol. 13, 5877–
5887.
Qian, D., Sperling, A.I., Lancki, D.W., Tatsumi, Y., Barrett, T.A., Blue-
stone, J.A., and Fitch, F.W. (1993). The g chain of the high-affinity
receptor for IgE is a major functional subunit of the T-cell antigen
receptor complex in gd T lymphocytes. Proc. Natl. Acad. Sci. USA
90, 11875–11879.
Racioppi, L., and Germain, R.N. (1995). Modified T-cell receptor
ligands: moving beyond a strict occupancy model for T-cell activa-
tion by antigen. Chem. Immunol. 60, 79–99.
Rayter, S.I., Woodrow, M., Lucas, S.C., Cantrell, D.A., and Down-
ward, J. (1992). p21ras mediatescontrol of IL-2 gene promoter func-
tion in T cell activation. EMBO J. 11, 4549–4556.
Reth, M. (1989). Antigen receptor tail clue. Nature 338, 383–384.
Saito, H., Kranz, D.M., Takagaki, Y., Hayday, A.C., Eisen, H.N., and
